3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
8
Stomach Neoplasms
5
Colorectal Neoplasms
4
Pancreatic Neoplasms
3
Pain, Postoperative
3
Myoma
3
Warts
2
Rectal Neoplasms
2
Meningioma
2
Lung Neoplasms
2
Urolithiasis
1
Surgery
1
Skin Diseases
1
Sigmoid Neoplasms
1
Sarcoma
1
Recurrence
1
Radiodermatitis
1
Prostatic Neoplasms
1
Pneumoperitoneum
1
Pharyngitis
1
Peripheral Nervous System Diseases
1
Ovarian Neoplasms
1
Neuroma
1
Neuralgia
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Multiple Endocrine Neoplasia Type 1
1
Melanoma
1
Maxillofacial Tumors
1
Interventions
Sodium Chloride
1
Lidocaine
1
Hyperthermic Intraperitoneal Chemotherapy
1
Cystectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Invasive Bladder Cancer
×
Sodium Chloride
×
Clear all
NCT02924480
2022-03-09
Lidocaine
CAMC Health System
Phase NA
Completed
50 enrolled